SOUTH SAN FRANCISCO, Calif., March 03, 2016 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...
Healios receives rights to develop and commercialize additional indications and Athersys receives $20 million ...
Adds two revenue-generating FDA-licensed vaccines that protect against cholera and typhoid fever, both with ...
